Global Health

Latest on Human Papilloma Virus Vaccine for Cervical Cancer

John Schiller
John Schiller

John Schiller, National Cancer Institute, Bethesda
The human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectious disease and cancer. Delegates at the ICAAC conference heard an update on both the anti-cancer and the anti-wart activities of the two vaccines: one from Merck and the other from GlaxoSmithKline.

Click here for all the interviews from ICAAC 2005

Similar Interviews

  • Audio Journal of Oncology 13.8, December 2005
  • Reporting from: ECCO-13 The European Cancer Conference, Paris, October 30–November 3, 2005 In this edition: Martine Piccart gave the Paris ECCO conference her

  • Audio Journal of Oncology in Advance - June 1st, 2007 - reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles">Audio Journal of Oncology in Advance - June 1st, 2007 - reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles
  • Lawrence Wickerham Invasive Breast Cancer Chemoprevention Trials Assessed REFERENCE: ABSTRACT Special Session; American Association for Cancer

  • Audio Journal of Oncology 13.1, January 2005
  • Reporting from: - European Society for Medical Oncology Congress, October 29-November 10, 2004, Vienna - Journal of Clinical Oncology - New England Journal

    Post a comment

    Subscribe to Audio Medica Podcast